Sanofi | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
AbbVie USD 5.18B 349M 2025-03
Amgen USD 8.81B 3.16B 2025-03
AstraZeneca USD 7.06B 1.83B 2025-06
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Canopy Growth CAD 16.31M 69.8M 2024-12
Corcept Therapeutics USD 89.82M 37.85M 2025-03
Drreddys Laboratories INR 1.1B 743M 2024-12
Eli Lilly USD 3.09B 175.1M 2025-03
Galapagos EUR 108.07M 43.83M 2025-03
Genmab DKK 1.62B 8.24B 2025-03
GlaxoSmithKline GBP 3.6B 865M 2025-06
Glaxosmithkline GBP 3.87B 678M 2024-12
J&J USD 38.47B 32.35B 2025-03
Merck USD 8.63B 4.61B 2025-03
Novartis USD 6.66B 410M 2025-06
Novartis USD 11.46B 2.15B 2024-12
Pacira USD 283.61M 6.84M 2025-03
Perrigo USD 409.9M 148.9M 2025-03
Pfizer USD 1.43B 387M 2025-03
Prestige Brands USD 97.88M 47.01M 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
Sanofi 7.44B 646M 2024-12
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
UCB EUR 1.57B 1.14B 2024-12
Zoetis USD 1.72B 264M 2025-03


Sanofi Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.